Further supporting that mTOR inhibition may represent a relevant therapy for brain tumors in NF1, preliminary clinical studies confirmed unequivocal efficacy of rapamycin and its analogs to reduce the growth of plexiform neurofibroma [47] or low-grade glioma [48] observed in some patients with NF1. Here, MTOR is linked to neurofibromatosis type 1.